JP2008506632A5 - - Google Patents

Download PDF

Info

Publication number
JP2008506632A5
JP2008506632A5 JP2006554374A JP2006554374A JP2008506632A5 JP 2008506632 A5 JP2008506632 A5 JP 2008506632A5 JP 2006554374 A JP2006554374 A JP 2006554374A JP 2006554374 A JP2006554374 A JP 2006554374A JP 2008506632 A5 JP2008506632 A5 JP 2008506632A5
Authority
JP
Japan
Prior art keywords
trp
azagly
asn
tyr
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006554374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008506632A (ja
JP4346650B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/012021 external-priority patent/WO2006001499A2/en
Publication of JP2008506632A publication Critical patent/JP2008506632A/ja
Publication of JP2008506632A5 publication Critical patent/JP2008506632A5/ja
Application granted granted Critical
Publication of JP4346650B2 publication Critical patent/JP4346650B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006554374A 2004-06-25 2005-06-23 メタスチン誘導体およびその用途 Expired - Fee Related JP4346650B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004187671 2004-06-25
JP2004363311 2004-12-15
PCT/JP2005/012021 WO2006001499A2 (en) 2004-06-25 2005-06-23 Metastin derivatives and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008245073A Division JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途

Publications (3)

Publication Number Publication Date
JP2008506632A JP2008506632A (ja) 2008-03-06
JP2008506632A5 true JP2008506632A5 (enExample) 2008-11-13
JP4346650B2 JP4346650B2 (ja) 2009-10-21

Family

ID=34971534

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006554374A Expired - Fee Related JP4346650B2 (ja) 2004-06-25 2005-06-23 メタスチン誘導体およびその用途
JP2008245073A Expired - Fee Related JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途
JP2009132363A Pending JP2009227687A (ja) 2004-06-25 2009-06-01 メタスチン誘導体およびその用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2008245073A Expired - Fee Related JP4654284B2 (ja) 2004-06-25 2008-09-25 メタスチン誘導体およびその用途
JP2009132363A Pending JP2009227687A (ja) 2004-06-25 2009-06-01 メタスチン誘導体およびその用途

Country Status (20)

Country Link
US (2) US7625869B2 (enExample)
EP (2) EP2113513B1 (enExample)
JP (3) JP4346650B2 (enExample)
CN (2) CN101863971A (enExample)
AR (1) AR049938A1 (enExample)
AU (1) AU2005257484A1 (enExample)
BR (1) BRPI0512397A (enExample)
CA (1) CA2571420A1 (enExample)
CL (1) CL2008003730A1 (enExample)
CR (1) CR8828A (enExample)
IL (1) IL179640A0 (enExample)
MA (1) MA28903B1 (enExample)
MX (1) MXPA06014206A (enExample)
NO (1) NO20065957L (enExample)
NZ (1) NZ552029A (enExample)
PE (2) PE20060371A1 (enExample)
RU (1) RU2006145886A (enExample)
SG (1) SG153865A1 (enExample)
TW (1) TW200607816A (enExample)
WO (1) WO2006001499A2 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1494732B1 (en) 2002-03-20 2008-01-30 MannKind Corporation Inhalation apparatus
AU2003292696A1 (en) 2002-12-26 2004-08-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
EP1604682A4 (en) 2003-03-12 2009-06-24 Takeda Chemical Industries Ltd AGENTS IMPROVING GONADIC FUNCTION
AU2005245338B2 (en) 2004-04-08 2011-11-17 Biomatrica, Inc. Integration of sample storage and sample management for life science
MXPA06014206A (es) 2004-06-25 2007-02-14 Takeda Pharmaceutical Derivados de metastina y uso de los mismos.
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
AU2006290227B2 (en) 2005-09-14 2012-08-02 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
TWI386417B (zh) * 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
US8404643B2 (en) * 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090093615A1 (en) * 2005-12-22 2009-04-09 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
KR20080096809A (ko) 2006-02-22 2008-11-03 맨카인드 코포레이션 디케토피페라진 및 활성제를 포함하는 마이크로입자의 약학특성의 개선 방법
US8183212B2 (en) * 2006-04-26 2012-05-22 Kyoto University Compound having GPR54 agonistic activity
ITMI20061607A1 (it) * 2006-08-09 2008-02-10 Maria Vincenza Carriero Peptidi con attivita farmacologica
TWI404726B (zh) * 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
CN101528772B (zh) * 2006-10-25 2013-03-13 武田药品工业株式会社 Metastin衍生物及其用途
EP2277900A4 (en) * 2008-04-24 2011-08-03 Takeda Pharmaceutical METASTINE DERIVATIVE AND ITS USE
EP2275433B1 (en) * 2008-04-30 2017-06-07 Kyoto University Metastin derivative and use thereof
SG10201507036TA (en) 2008-06-13 2015-10-29 Mannkind Corp A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
US20110212890A1 (en) * 2008-07-30 2011-09-01 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
CA2748517A1 (en) * 2008-12-29 2010-07-08 Takeda Pharmaceutical Company Limited Prophylactic/therapeutic agent for cancer
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8716228B2 (en) 2009-05-27 2014-05-06 Yeda Research And Development Co. Ltd. GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
UY33127A (es) 2009-12-22 2011-07-29 Takeda Pharmaceutical Formulación de liberación sostenida
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US9127038B2 (en) 2011-08-04 2015-09-08 Merck Sharp & Dohme Corp. Kisspeptide-pentasaccharide conjugates
HK1200318A1 (en) 2011-10-24 2015-08-07 曼金德公司 Methods and compositions for treating pain
JP2015511600A (ja) 2012-03-14 2015-04-20 イェダ リサーチ アンド ディベロップメント カンパニー リミテッド 修飾キスペプチンペプチドおよびその使用
EP2872205B1 (en) 2012-07-12 2017-02-08 MannKind Corporation Dry powder drug delivery systems
EP3249054A1 (en) 2012-12-20 2017-11-29 Biomatrica, INC. Formulations and methods for stabilizing pcr reagents
JP6143270B2 (ja) * 2013-01-31 2017-06-07 学校法人東京薬科大学 マイオスタチン阻害ペプチド
KR102465025B1 (ko) 2013-07-18 2022-11-09 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
US10220069B2 (en) * 2014-01-22 2019-03-05 The Johns Hopkins University Compositions and methods for treating diabetes
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015191632A1 (en) 2014-06-10 2015-12-17 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
KR102589056B1 (ko) 2015-12-08 2023-10-12 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
MA46353A (fr) 2016-09-30 2019-08-07 Myovant Sciences Gmbh Méthodes de traitement de l'infertilité féminine
CN109206481B (zh) 2017-07-05 2023-08-18 尚华医药科技(江西)有限公司 一种肽类化合物、其应用及含其的组合物
CN108752233B (zh) * 2018-07-18 2020-10-16 河北师范大学 小分子凝胶因子、凝胶材料及制备方法和应用
CN115515937A (zh) * 2020-05-08 2022-12-23 范因斯坦医学研究院 用于合成肽模拟物的二聚体
WO2025217074A1 (en) 2024-04-08 2025-10-16 Radionetics Oncology, Inc. Kisspeptin receptor (kiss1r) targeted therapeutics and uses thereof

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
FR2488253A1 (fr) * 1980-08-08 1982-02-12 Roques Bernard Nouveaux peptides et leur application en therapeutique
IL74827A (en) * 1984-05-21 1989-06-30 Salk Inst For Biological Studi Peptides active as gnrh antagonists and pharmaceutical compositions containing them
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
AU7333496A (en) 1995-10-19 1997-05-07 Takeda Chemical Industries Ltd. Quinoline derivatives as gnrh antagonists
JPH09169735A (ja) 1995-10-19 1997-06-30 Takeda Chem Ind Ltd キノリン誘導体、その製造法および用途
AU2382097A (en) 1996-04-19 1997-11-12 Novo Nordisk A/S Compounds with growth hormone releasing properties
CA2283299A1 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
JP4486187B2 (ja) 1998-10-27 2010-06-23 武田薬品工業株式会社 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
HK1047045A1 (zh) 1999-06-28 2003-02-07 Abbott Gmbh & Co. Kg 預防腫瘤生長的方法
US6638906B1 (en) 1999-12-13 2003-10-28 Nobex Corporation Amphiphilic polymers and polypeptide conjugates comprising same
WO2001044469A1 (fr) 1999-12-17 2001-06-21 Takeda Chemical Industries, Ltd. PROCEDE DE PRODUCTION DE PEPTIDE KiSS-1
JP2001231581A (ja) * 1999-12-17 2001-08-28 Takeda Chem Ind Ltd ＫｉＳＳ−１ペプチドの製造法
HUP0500345A2 (hu) 2000-03-29 2005-07-28 Corixa Corporation Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására
CA2404257A1 (en) 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Novel protein, dna thereof and process for producing the same
US7834141B1 (en) 2000-03-31 2010-11-16 Theresa Siler-Khodr Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
RU2311920C2 (ru) 2000-09-20 2007-12-10 Корикса Корпорейшн Композиции и способы для лечения и диагностики рака легких
JP2003026601A (ja) 2000-11-29 2003-01-29 Takeda Chem Ind Ltd 医薬組成物およびその製造法
JP2002320496A (ja) 2001-02-26 2002-11-05 Takeda Chem Ind Ltd 新規マウス型ＫｉＳＳ−１レセプタータンパク質およびそのＤＮＡ
WO2002085399A1 (fr) 2001-04-20 2002-10-31 Takeda Chemical Industries, Ltd. Preparations contenant un peptide
US20040185525A1 (en) * 2001-05-17 2004-09-23 Osamu Nishimura Process for producing peptide
ATE360034T1 (de) * 2001-09-19 2007-05-15 Takeda Pharmaceutical Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
EP1466976A4 (en) 2002-01-11 2005-11-09 Takeda Pharmaceutical PROCESS FOR PREPARING KISS-1 PEPTIDES
JP2003300906A (ja) 2002-04-12 2003-10-21 Daiichi Fine Chemical Co Ltd がん転移抑制因子の安定化
US20060035875A1 (en) 2002-10-09 2006-02-16 Yukimasa Shiotsu Remedy for hormone-dependent cancer
CA2503164A1 (en) 2002-10-25 2004-05-06 Paradigm Therapeutics Limited Gpr54 knock-out mammals and screening methods using them
JP4804714B2 (ja) 2002-12-26 2011-11-02 武田薬品工業株式会社 メタスチン誘導体およびその用途
AU2003292696A1 (en) 2002-12-26 2004-08-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
US6800611B2 (en) 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
KR100595364B1 (ko) 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
EP1604682A4 (en) 2003-03-12 2009-06-24 Takeda Chemical Industries Ltd AGENTS IMPROVING GONADIC FUNCTION
EP1464652A1 (en) 2003-04-02 2004-10-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases
US20050002935A1 (en) 2003-04-17 2005-01-06 Vincent Ling Use of B7-H3 as an immunoregulatory agent
CA2523600A1 (en) 2003-04-28 2004-11-11 Wyeth Methods utilising g-protein coupled receptor 54
WO2004101747A2 (en) 2003-05-07 2004-11-25 The General Hospital Corporation Identification and use of gpr54 and its ligands for reproductive disorders and contraception
US20070155803A1 (en) 2003-05-30 2007-07-05 Prozymex A/S Protease inhibitors
JP4688678B2 (ja) 2003-11-03 2011-05-25 北京沙東生物技術有限公司 抗癌作用を有する組換えタンパク質、それをコードする遺伝子、及びそれらの使用
RU2333221C2 (ru) 2003-11-03 2008-09-10 Бейцзин Санбио Байотек Ко., Лтд. Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
WO2005095973A2 (en) 2004-03-25 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
CA2562676A1 (en) 2004-04-23 2005-12-15 Applied Research Systems Ars Holding N.V. Use of gpcr54 ligands for the treatment of infertility
MXPA06014206A (es) 2004-06-25 2007-02-14 Takeda Pharmaceutical Derivados de metastina y uso de los mismos.
WO2007084211A2 (en) 2005-11-11 2007-07-26 The General Hospital Corporation Use of gpr54 ligands for treatment of reproductive disorders, proliferative disorders, and for contraception
US20090099334A1 (en) 2005-12-22 2009-04-16 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US20090093615A1 (en) 2005-12-22 2009-04-09 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
TWI386417B (zh) 2005-12-22 2013-02-21 Takeda Pharmaceutical 轉移抑素衍生物及其用途
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JP2009530379A (ja) 2006-03-20 2009-08-27 メルク エンド カムパニー インコーポレーテッド ニューロメジンｕ受容体アゴニスト及びその使用
WO2007109857A1 (en) 2006-03-28 2007-10-04 Biopharmica Ltd Agent for the treatment of hormone-dependent disorders and uses thereof
TWI404726B (zh) 2006-10-25 2013-08-11 Takeda Pharmaceutical 腫瘤轉移抑制素衍生物及其用途
WO2009044918A1 (ja) 2007-10-05 2009-04-09 Takeda Pharmaceutical Company Limited ニューロメジンｕ誘導体
EP2277900A4 (en) 2008-04-24 2011-08-03 Takeda Pharmaceutical METASTINE DERIVATIVE AND ITS USE
EP2340047A1 (en) 2008-09-19 2011-07-06 Nektar Therapeutics Polymer conjugates of kiss1 peptides

Similar Documents

Publication Publication Date Title
FIC20253005I1 (fi) Seladelpaarin L-lysiinisuola, erityisesti seladelpaari-L-lysiinidihydraatti
JP2010501534A5 (enExample)
JP2006526031A5 (enExample)
NO2018037I1 (no) Simeprevir, eller salt derav, innbefattende natrium-simeprevir
JP2007522220A5 (enExample)
JP2005518413A5 (enExample)
DK1902037T3 (da) 2,4-diamino-pyrimidiner som auroainhibitorer
JP2009520682A5 (enExample)
NL300703I2 (nl) Simeprevir, of een farmaceutisch aanvaardbaar zout daarvan, waaronder simeprevirnatrium.
JP2010500116A5 (enExample)
JP2008514563A5 (enExample)
JP2006524283A5 (enExample)
JP2006503588A5 (enExample)
BRPI0810646A2 (pt) " compostos farmacêuticos ".
ATE477257T1 (de) Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
NO20053762D0 (no) Kondensert furanforbindelse.
JP2007119504A5 (enExample)
JP2004149545A5 (enExample)
ATE531717T1 (de) Neue kristalline form eines pyridazinoä4,5- büindolderivats
JP2006339594A5 (enExample)
JP2003160581A5 (enExample)
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
JP2006506499A5 (enExample)